<DOC>
	<DOCNO>NCT00832052</DOCNO>
	<brief_summary>Evaluate safety tolerability PF-04447943 administration multiple dose healthy elderly participant . Evaluate plasma drug level effect cognition .</brief_summary>
	<brief_title>A Study Evaluate Safety , Tolerability , Plasma Drug Levels , Cognitive Response Following Multiple Doses Drug Healthy Elderly Participants .</brief_title>
	<detailed_description />
	<criteria>Healthy male and/or female subject . Subjects must reasonably good health determine investigator base medical history , full physical examination ( include blood pressure pulse rate measurement ) , 12 lead ECG clinical laboratory test . Subjects mild , chronic , stable disease ( eg , control hypertension , noninsulin dependent diabetes , osteoarthritis may enrol deem medically prudent investigator . Subjects take daily prescription nonprescription medication management acceptable chronic medical condition must stable dose . Body Mass Index ( BMI ) 18 30 kg/m2 , inclusive ; total body weight &gt; 50 kg ( 110 lb ) . Creatinine clearance great 30 mL/min use CockcroftGault method . Subjects evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , immunologic , allergic disease . Use tobacco form nicotine past 6 month . Greater 7 drink alcohol per week woman , great 14 drink alcohol per week men .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>elderly , multi-dose , safety , efficacy</keyword>
</DOC>